Newsroom-Katalog

Zeit	Takeda Pharma Vertrieb GmbH & Co. KG: Meldungen vom 17.11.2023
16:11	The European Commission Approves Label Update for TAKHZYRO® (lanadelumab), Expanding Its Use to a Broader Group of Paediatric Patients with Recurrent Attacks of Hereditary Angioedema (HAE)